294 related articles for article (PubMed ID: 9214602)
1. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
Yu MW; Chiang YC; Lien JP; Chen CJ
Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
[TBL] [Abstract][Full Text] [Related]
2. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
3. Influence of vitamins A, C, and E and beta-carotene on aflatoxin B1 binding to DNA in woodchuck hepatocytes.
Yu MW; Zhang YJ; Blaner WS; Santella RM
Cancer; 1994 Feb; 73(3):596-604. PubMed ID: 8299081
[TBL] [Abstract][Full Text] [Related]
4. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan.
Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ
J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607
[TBL] [Abstract][Full Text] [Related]
5. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1.
Chen SY; Chen CJ; Tsai WY; Ahsan H; Liu TY; Lin JT; Santella RM
Nutr Cancer; 2000; 38(2):179-85. PubMed ID: 11525595
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
7. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
8. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue.
Santella RM; Zhang YJ; Chen CJ; Hsieh LL; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M
Environ Health Perspect; 1993 Mar; 99():199-202. PubMed ID: 8391434
[TBL] [Abstract][Full Text] [Related]
11. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
12. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue.
Zhang YJ; Chen CJ; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M; Santella R
Carcinogenesis; 1991 Dec; 12(12):2247-52. PubMed ID: 1721008
[TBL] [Abstract][Full Text] [Related]
13. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
[TBL] [Abstract][Full Text] [Related]
14. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):846-53. PubMed ID: 19273485
[TBL] [Abstract][Full Text] [Related]
15. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
16. Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype.
Ahsan H; Wang LY; Chen CJ; Tsai WY; Santella RM
Environ Health Perspect; 2001 Aug; 109(8):833-7. PubMed ID: 11564620
[TBL] [Abstract][Full Text] [Related]
17. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
[TBL] [Abstract][Full Text] [Related]
19. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Chen CJ; Zhang YJ; Lu SN; Santella RM
Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
[TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B1-induced toxicity in HepG2 cells inhibited by carotenoids: morphology, apoptosis and DNA damage.
Reddy L; Odhav B; Bhoola K
Biol Chem; 2006 Jan; 387(1):87-93. PubMed ID: 16497168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
